Since 2000, Innovaderm has conducted clinical studies on a vast range of dermatological conditions:
All phototypes in adults, adolescents, children and the elderly
Oral, subcutaneous, injectable (including IV), topical and patch
New Chemical Entity (NCE), biologics, dermal fillers, natural health products, cannabinoid derivatives, etc.
Innovaderm conducts safety and efficacy studies in dermatology. Some involve systemic compounds while others involve topical compounds.
Examples of studies that use systemic compounds are:
Examples of studies that use topical compounds are:
We also perform non-invasive valuations of a study’s Therapeutic Effects. Among the procedures we use: